MINNEAPOLIS – January 31, 2007 - Humanetics Corporation announced today that it has recently received notification from the United States Patent and Trademark Office that 7-Keto®, it’s flagship weight loss ingredient, has been granted a patent for modulating the basal metabolic rate & effecting weight loss, when administered in combination with a diet. This patent adds to the more than 25 patents already granted for varying uses of 7-Keto, including weight loss.
7-Keto is a naturally occurring substance produced by the body in the adrenal glands and that production declines with age. It works naturally with the body to enhance the activity of three key fat burning, thermogenic enzymes. The up-regulation of these key enzymes results in a higher metabolic rate and clinical studies have shown that administration of 7-Keto increases metabolism by 5.4%, promotes weight loss without stimulants and produces 3 times more weight loss than diet & exercise alone.
“This is significant news for Humanetics,” says Scott Steil, VP of Sales & Marketing, Humanetics Corporation. “It serves to strengthen the brand by patenting 7-Keto’s ability to affect metabolism in a safe way that encourages weight loss, in conjunction with diet & exercise. And that’s great news for 7-Keto customers who now have the strength of yet another patent behind the 7-Keto products that they sell and the weight loss claims that they make.”
About Humanetics Corporation
Founded in 1988, Humanetics Corporation is a privately held corporation focused on providing proprietary, science-based solutions to consumer health and aging concerns. Humanetics Corporation markets 7-Keto® for weight loss, MicroLactin® for inflammation and joint health and Inzitol™ for glucose transport and creatine uptake by muscle cells. For more information, visit www.humaneticsingredients.com.
Contact: Scott Steil